An overview of the biological disease modifying drugs available for arthritic conditions in South Africa
The past decade has seen a major change in the treatment options and strategies for rheumatoid arthritis (RA) and the other immune-mediated arthritic diseases. The disease modifying antirheumatic drugs (DMARDs) are now used in early stages of the disease in order to preserve joint architecture. Ther...
Guardado en:
Autores principales: | Leonie Harmse, Helmuth Reuter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
AOSIS
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1248f4fe9d1e473a9708a3ac6323da8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
por: A. A. Alshevskaya, et al.
Publicado: (2012) -
Management of chronic ocular sarcoidosis: challenges and solutions
por: Matsou A, et al.
Publicado: (2018) -
Biological evaluation of novel 6-Arylbenzimidazo [1,2-c] quinazoline derivatives as inhibitors of LPS-induced TNF- alpha secretion
por: GALARCE,GLORIA D, et al.
Publicado: (2008) -
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Georgios Kokolakis, et al.
Publicado: (2021) -
Immunological strategy for detecting the pro-inflammatory cytokine TNF-alpha in salmonids
por: Rojas,Verónica, et al.
Publicado: (2012)